Project Grant HT9425261E285
Award Date 8/15/26
Completion Date 8/14/30
Dollars Obligated $878K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94103, USA
Similar Awards
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $865,284 Project Grant award dated August 15, 2026, from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The award supports a four-year research initiative titled "Biochemical and Structural Targeting of the GAQ-Mutant Melanoma Subtype," with completion scheduled for August 14, 2030. This project conducts advanced biomedical research...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $1,054,812 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective August 15, 2026, through August 14, 2030. The grant funds research focused on "Biochemical and Structural Targeting of the GAQ-Mutant Melanoma Subtype," with performance conducted at UCSF's San Francisco, California facility. Under this award, UCSF will...
- This federal Project Grant award of $1,041,595.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF) on September 1, 2024. The award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, this 3-year Melanoma Research Program Team Science Award will fund innovative and...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $1.4 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2026, through July 31, 2029. The award funds research investigating metabolic mechanisms of resistance to mutant isocitrate dehydrogenase (IDH) inhibition in gliomas, with work performed at UCSF's San Francisco campus. This three-year research...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $1,620,505 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective June 1, 2026, through May 31, 2029. The award funds research and development services focused on "Novel Mitochondrial Metabolism Inhibitors for Aggressive and Treatment-Resistant MYC-High Breast Cancers," with research activities conducted at...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $1.7M Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period July 1, 2026 through June 30, 2029. The award supports research to develop PVRL2 (Poliovirus Receptor-Related 2) as a therapeutic target and biomarker for prostate cancer immunotherapy. This research initiative aligns with the DHA's mission to transform...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $1,226,730 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025, through July 31, 2029. The award funds research investigating the canonical Polycomb Repressive Complex 1 (cPRC1) as an intrinsic mechanism of resistance to enzalutamide in advanced prostate cancer. This hypothesis-driven research initiative...
- Federal Project Grant Award Summary The University of California, San Francisco (UCSF) received a $328,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025, through June 30, 2027. The award funds research on intracranial drug delivery strategies targeting skull bone marrow to generate antitumoral myeloid cell immune responses against glioblastoma. This research initiative represents UCSF's...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $1,594,419 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the project "Radiopathomic Mapping of Tumor Burden for Personalized Management of IDH-Mutant Glioma." The award, effective September 1, 2025, through August 31, 2028, supports advanced biomedical research focused on developing innovative diagnostic and...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $1.97M Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025, through June 30, 2028. The award supports the development of CD46-targeted antibody fragment radiopharmaceutical therapy for prostate cancer treatment. This research initiative represents a translational medicine effort to advance diagnostic and...